final drug study (eclampsia patient)

Upload: hazel-oclarit-cabrera

Post on 06-Apr-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    1/28

    GenericName

    (BrandName)

    Dosage,Timing

    andRoute

    ClassificationGeneral Class

    and Family

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    Lactulose(Duphalac)

    15cc,(HS)OD, PO

    Ammoniareductiondrug

    Laxative

    Treatment ofconstipationPreventionand treatmentof postal-systemicencephalopath

    y

    Drug passesunchanged intocolon wherebacteria break itdown to organicacid that increasethe osmotic

    pressure in colonand slightlyacidify coloniccontents resultingin increase stoolwater content,stool softening.This also result inmigration of bloodammonia into

    colon contentswith subsequenttrapping andexpulsion infeces.

    GI: flatulence,distention,intestinalcramps,belching,diarrhea,nausea

    Other: acid-baseimbalance,electrolyteimbalance

    Extremely darkor cloudy syrupmay be unsafe.Dont use.

    Give with fruitjuice, water or

    milk

    Administerretention enemausing rectalballoon catheter,dont usecleansing enema

    Dont administer

    with otherlaxative

    Monitor serumammonia levelCarefully monitorblood glucoselevels in diabeticpatients

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    2/28

    Generic Name(Brand Name)

    Dosage,Timing

    andRoute

    ClassificationGeneral Class

    and Family

    Indications Mechanismof Action

    Side Effects Nursing Considerations

    KetorolacTromethamine(Acular LS,Acular PF)

    10 mg(1tab),q8, PO

    Antipyr

    etic

    Nonopi

    oid

    analges

    ic

    NSAID

    Short-termmanagement of pain(up to 5days)

    Opthalmic:relief ofocularitching dueto seasonalconjuctivitisand relief ofpostopearativeinflammation aftercataractsurgery

    Anti-inflammatoryandanalgesicactivity,inhibitsprostaglandi

    ns andleukotrienesynthesis

    CNS: drowsiness,abnormalthinking,dizziness,euphoria,headacheRESP: asthma,

    dyspneaCV:Edema, pallor,vasodilationGI:GI Bleeding,abnormal taste,diarrhea, drymouth,dyspepsia, GI

    pain, nauseaGU:Oliguria,renal toxicity,urinary frequencyDERMA:pruritis,purpura,sweating,urticaria

    Patients who haveasthma, aspirin-inducedallergy, and nasal polypsare at increased risk fordevelopinghypersensitivityreactions. Assess for

    rhinitis, asthma, andurticaria.

    Assess pain (note type,location, and intensity)prior to and 1-2 hrfollowing administration

    Ketorolac therapyshould always be given

    initially by the IM or IVroute. Oral therapyshould be used only asa continuation ofparenteral therapy.

    Caution patient to avoidconcurrent use ofalcohol, aspirin,

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    3/28

    HEMA:prolongedbleeding timeLOCAL: injection

    site pain NEURO:paresthesiaMISC:allergic reaction,anaphylaxis

    NSAIDs,acetaminophen, or otherOTC medicationswithout consulting health

    care professional.

    Advise patient to consultif rash, itching, visualdisturbances, tinnitus,weight gain, edema,black stools, persistentheadche, or influenza-like syndromes(chills,fever,muscles

    aches, pain) occur.

    Effectiveness of therapycan be demonstrated bydecrease in severity ofpain. Patients who donot respond to oneNSAIDs may respond toanother.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    4/28

    GenericName(BrandName)

    Dosage,TimingandRoute

    ClassificationGeneralClass andFamily

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    N-Acetylcysteine

    (Broncoflem)

    20mgsachet+ 50

    mLwater,BIDOD,PO

    Respir

    atory

    and

    intratracheal

    inhala

    nt

    Mucoly

    tic

    An

    Antidot

    e.

    adjuncttreatment forabnormally

    viscid mucoussecretionspresent in acuteand chronicbronchopulmonary disease andpulmonarycomplication ofcystic fibrosis,tracheostomy

    care

    treatment ofacetaminophenoverdose.prevention ofrenal damagefrom dyes givenduring certain

    Acetylcysteine splitslinkage ofmucoproteins. It

    reduces theviscosity ofpulmonarysecretions,facilitates removalby coughing,postural drainage,mechanical means.Acetylcysteineprotects against

    acetaminophenoverdose-inducedliver toxicity.

    Stickiness onface

    Transientunpleasant odor

    Increasedbronchialsecretions

    Irritated throat

    Nausea

    Vomiting

    Rhinorrhea

    Skin rash

    Assesspretreatment

    respirations forrate, depth, andrhythm.

    If bronchospasmoccurs, stop thetreatment andnotify thephysician.

    Monitor rate,depth, rhythm,and type ofrespiration

    Check sputum forcolor, consistencyand amount.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    5/28

    diagnostic testslike CT scan.

    Facial edema

    Bronchospasm

    Wheezing

    GenericName(BrandName)

    Dosage,TimingandRoute

    ClassificationGeneral Classand Family

    Indications Mechanism ofAction

    Side Effects Nursing Considerations

    Amlodipi

    ne(Alzor)

    10mg

    (1tab),OD, PO

    Calciu

    mchannel

    blocker

    anti-

    hyperte

    nsive

    anti-

    anginal.

    used to

    managehypertension, chronicstableangina, andvasospasticangina. Itmay beused aloneor with

    other anti-hypertensives or anti-anginals.

    Amlodipine

    inhibits calciummovementacross cellmembranes ofcardiac andvascularsmoothmuscle. Itdilatescoronary

    arteries,peripheralarteries andarterioles.Amlodipinedecreases totalperipheralvascularresistance by

    Peripheraledema

    Headache

    Flushing

    Dizziness

    Palpitations

    Nausea

    Unusualtiredness orweakness

    Chest pain

    Assess baseline renaland liver function.

    Assess blood pressure.

    Assess apical pulse.

    Assess for peripheraledema behind medialmalleolus.

    Assess skin forflushing.

    Question for headacheand weakness.

    May be given without

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    6/28

    vasodilation. Bradycardia

    OrthostaticHypotension

    regards to food.

    Grapefruit juice mayincrease drug

    concentration

    GenericName(BrandName)

    Dosage,TimingandRoute

    ClassificationGeneralClassandFamily

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    Furosemide(Lasix)

    50mg(1tab),OD, PO

    Loopdiuretic

    Treatment ofedemaassociated withcongestiveheart failure,chronic renalfailure, hepaticcirrhosis, andacute

    pulmonaryedema

    It is also usedfor treatment ofhypertension,alone or incombinationwith other

    Enhancesexcretion ofsodium,chloride,potassium bydirect action atascendinglimb of loop ofHenle and

    produces adiuretic effect.

    Increase inurinaryfrequency orvolume

    Nausea

    Gastric upset

    with cramping

    Diarrhea orconstipation

    Electrolytedisturbances

    Dizziness or light

    Give with food toavoidgastroinestinalupset, preferablywith breakfast (toprevent nocturia).

    Check vital signs

    especially bloodpressure forhypotension priorto administration.

    Assess baselineelectrolyte,particularly check

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    7/28

    hypertensive

    Can also beused for

    treatment ofhypercalcemia.

    headedness

    Headache

    Blurred Vision

    Paresthesia

    Photosensitivity

    Rash

    Weakness

    Bladder spasm

    for low potassium.

    Assess edema,skin turgor, and

    mucousmembranes forhydration status.

    Assess musclestrength andmental status.

    Obtain baselineweight..

    Note extent ofdiuresis

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    8/28

    GenericName(BrandName)

    Dosage,TimingandRoute

    ClassificationGeneral Classand Family

    Indications Mechanism ofAction

    Side Effects Nursing Considerations

    Metropol

    ol(Lopressor)

    100mg

    (1tab),BID, PO

    autonomic

    nervoussystem

    agent

    beta-

    adrenergic

    antagonist

    (sympathol

    ytic);

    antihyperte

    nsive

    Metoprolol

    isprescribedfor patientswith highbloodpressure(hypertensionIt is alsoused totreat chestpain(anginapectoris)related tocoronaryarterydisease.slowing and

    Metoprolol

    blocks theaction of thesympatheticnervoussystem, aportion of theinvoluntarynervoussystem, byblocking betareceptors onsympatheticnerves. Sincethesympatheticnervoussystem isresponsible forincreasing the

    Constipation;

    diarrhea;dizziness; drymouth or eyes;gas; headache;heartburn;lightheadedness; milddrowsiness;muscle aches;nausea;stomach pain;trouble sleeping;unusualtiredness orweakness;vomiting.

    Take apical pulse andBP beforeadministering drug.Report to physiciansignificant changes inrate, rhythm, or qualityof pulse or variationsin BP prior toadministration.

    Monitor BP, HR, andECG carefully duringIV administration.

    Take several BPreadings close to theend of a 12 h dosinginterval to evaluateadequacy of dosage

    http://www.medicinenet.com/script/main/art.asp?articlekey=87510http://www.medicinenet.com/script/main/art.asp?articlekey=87510http://www.medicinenet.com/script/main/art.asp?articlekey=87510http://www.medicinenet.com/script/main/art.asp?articlekey=87510
  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    9/28

    regulatingcertaintypes ofabnormally

    rapid heartrates

    Other usesinclude thepreventionof migraineheadacheandtreatment

    of certaintypes oftremors(familial orhereditaryessentialtremors).

    rate withwhich theheart beats,by blocking

    the action ofthese nervesmetoprololreduces theheart rate andis useful intreatingabnormallyrapid heartrhythms.

    for patients withhypertension,particularly in patientson twice daily doses.

    Some patients requiredoses 3 times a day tomaintain satisfactorycontrol.

    Monitor I&O, dailyweight; auscultatedaily for pulmonaryrales.

    Withdraw drug ifpatient presentssymptoms of mentaldepression because itcan progress tocatatonia.

    http://www.medicinenet.com/script/main/art.asp?articlekey=84544http://www.medicinenet.com/script/main/art.asp?articlekey=84544http://www.medicinenet.com/script/main/art.asp?articlekey=84544http://www.medicinenet.com/script/main/art.asp?articlekey=417http://www.medicinenet.com/script/main/art.asp?articlekey=417http://www.medicinenet.com/script/main/art.asp?articlekey=504http://www.medicinenet.com/script/main/art.asp?articlekey=504http://www.medicinenet.com/script/main/art.asp?articlekey=417http://www.medicinenet.com/script/main/art.asp?articlekey=417http://www.medicinenet.com/script/main/art.asp?articlekey=84544http://www.medicinenet.com/script/main/art.asp?articlekey=84544http://www.medicinenet.com/script/main/art.asp?articlekey=84544
  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    10/28

    GenericName(Brand

    Name)

    Dosage,Timing andRoute

    ClassificationGeneralClass and

    Family

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    Captopril(Capoten)

    125 mg(1tab), q6hold ifSBB

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    11/28

    renal failure,polyuria, oliguria,urinary frequencyHematologic:

    Neutropenia,agranulocytosis,thrombocytopenia,hemolytic anemia,pancytopeniaOther: Cough,malaise, drymouth,lymphadenopathy

    mark patient's chartwith notice thatcaptopril is beingtaken; the

    angiotensin IIformation subsequentto compensatoryrenin release duringsurgery will beblocked; hypotensionmay be reversed withvolume expansion.

    Monitor patientclosely for fall in BPsecondary toreduction in fluidvolume

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    12/28

    GenericName(Brand

    Name)

    Dosage,Timingand

    Route

    ClassificationGeneral Classand Family

    Indications Mechanism ofAction

    Side Effects Nursing Considerations

    Amikacin

    sulfate

    (Amikin)

    500mg,q12,IVTT

    Aminoglycoside Short-termtreatment ofseriousinfectionscaused bysusceptiblestrains ofPseudomonasspecies,Escherichia coli,indole-positiveand indole-negativeProteusspecies,Klebsiella,Enterobacter,and Serratiaspecies,Acinetobacterspecies.

    Bactericidal:Inhibits proteinsynthesis insusceptiblestrains of gram-negativebacteria cellmembraneappears to bedisrupted,causing celldeath.

    Ototoxicity,nausea,vomiting,diarrhea,superinfections

    Correct dehydrationbefore therapybecause of increase riskof toxicity.

    Watch for signs andsymptomsofsuper infection(especially URT),such as continuedfever, chills, andincreased pulse rate.

    Weigh patient andreview renalfunctionstudies beforetherapybegins.

    Evaluate patientshearing beforeand during therapy if hewill be receiving drug forlonger than 2weeks. Notify prescriberif patienthas tinnitus, vertigo, orhearing loss

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    13/28

    Obtain specimen forculture andsensitivity test beforegiving first

    dose. Therapy maybegin whileawaiting the results.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    14/28

    GenericName(Brand

    Name)

    Dosage,Timing andRoute

    ClassificationGeneral Classand Family

    Indications Mechanismof Action

    Side Effects NursingConsiderations

    Potassium

    Chloride

    (KaliumDurule)

    1 tab, PO Electrolytesand Minerals For hypokalemia

    As prophylaxisduring treatmentwith diuretics

    To prevent and

    treat potassium,

    deficitsecondary

    to diuretics or

    corticosteroid

    therapy.

    Also indicated

    when

    potassium,

    is depleted by

    severe vomiting,

    prolonged

    diuresis and

    diabetic

    acidosis.

    Supplementalpotassium inthe form ofhighpotassiumfoodor potassiumchloridemay be ableto restorenormalpotassiumlevels.

    Renal insufficiency,hyperkalemia,nausea, vomiting,muscle weakness,difficulty inswallowing

    Some patients

    find it difficult

    to swallow the

    large sized KCl

    tablet.

    Administer

    while patient is

    sitting up or

    standing (neverin recumbent

    position) to

    prevent drug-

    induced

    esophagus.

    Watch out forlevels of

    potassiumelectrolyte levelto preventhyperkalemia.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    15/28

    GenericName(BrandName)

    Dosage,TimingandRoute

    ClassificationGeneral Classand Family

    Indications Mechanism ofAction

    Side Effects Nursing Considerations

    Cefazolin

    (Ancef)

    500mg(1tab) q8,PO

    Anit-

    infectives

    Pharmacol

    ogic: first

    generation

    Cephalosp

    horins

    Skin & skinstructureinfections;pneumonia;urinary tractinfections;bone & jointinfections

    Bind to

    bacterial cell

    wall

    membrane,

    causing cell

    death.

    Active against

    many gram-positive cocciincluding:Streptococcuspneumoniae,Group A beta-hemolyticstreptococci;Penicillinas-producing

    staphylococci.

    diarrhea,nausea,vomiting,cramps,Rashes,allergicreactionsincludingAnaphylaxisand Serumsickness,superinfection

    Assess patient forinfection (vital signs;appearance of surgicalsite, urine; WBC) atbeginning and duringtherapy.

    Before initiatingtherapy, obtain a historyto determine previoususe of and reactions topenicillins orcephalosphorins.Persons with a negativehistory of penicillinsensitivity may still havean allergic response.

    Obtain specimens forculture and sensitivitybefore initiating therapy.

    Observe patient forsigns and symptoms ofanaphylaxis (rash,pruritis, laryngealedema, wheezing).Discontinue drug andnotify physician or other

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    16/28

    health care professionalimmediately if theseproblems occur. Keepepinephrine, anantihistamine, andresuscitation equipmentclose by in case ofanaphylactic reaction.

    Instruct patient to reportsigns of superinfection(furry overgrowth on thetongue, vaginal itchingor discharge, loose orfoul-smelling stools) andallergy.

    Instruct patient to notifyhealth care professionalif fever and diarrheadevelop, especially ifdiarrhea contains blood,mucus, or pus. Advisenot to treat diarrheawithout consultinghealthcare professional.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    17/28

    GenericName(BrandName)

    Dosage,TimingandRoute

    ClassificationGeneralClass andFamily

    Indications Mechanism ofAction

    Side Effects Nursing Considerations

    Paracetamol

    (Biogesic)

    300mg,STATorder,IVT

    Anti-pyretic Symptomatic

    relief of pain

    and fever.

    Acetaminophenrelieves pain byelevating the painthreshold, that is,by requiring agreater amount ofpain to developbefore a personfeels it. It reducesfever through itsaction on the heat-regulating centerof the brain.Specifically, it tellsthe center to lowerthe body'stemperature whenthe temperature iselevated.

    hemolyticanemia,

    neutropenia,leucopenia,

    pancytopenia,jaundice,

    hypoglycemia,rash, urticaria.

    Use liquid form forchildren andpatients who havedifficultyswallowing.

    Advise patient that drugis only for short termuse.

    Advise patient thatmany over the counterproducts containacetaminophen; beaware of this whencalculating total dailydose.

    Warn patient that highdoses orunsupervised long termuse cancause liver damage.

    Use cautiously inpatients with longterm alcohol use

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    18/28

    because therapeuticdoses causehepatotoxicity in thesepatients.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    19/28

    GenericName(BrandName)

    Dosage,TimingandRoute

    ClassificationGeneral Class and Family

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    Diazepam

    (Valium)

    5mg(1tab),STATorder,IVTT

    Benzodiazepine

    Anxiolytic

    Antiepileptic

    Skeletal muscle

    relaxant (centrallyacting)

    Managementof anxietydisorders orfor short-termrelief ofsymptoms ofanxiety.

    Exactmechanisms ofaction notunderstood; actsmainly at thelimbic systemand reticularformation; mayact in spinal cordand atsupraspinal sitesto produceskeletal musclerelaxation;potentiates theeffects of GABA,an inhibitoryneurotransmitter;anxiolytic effectsoccur at doseswell below thosenecessary tocause sedation,ataxia; has littleeffect on corticalfunction.

    Throat, chestpain,

    drowsiness,fatigue,

    confusion,dizziness,headache,

    slurred speech,hypotension,tachycardia,

    edema, blurredvision, nausea,constipation,

    urinaryretention,hiccups,

    coughing.

    Superviseambulation.Adversereactions suchas drowsinessand ataxia aremore likely tooccur in olderadults anddebilitated orthose receivinglarger doses.Dosageadjustment maybe necessary.

    Monitor I and Oratio, includingurinary andbowelelimination.

    Observe patientclosely andmonitor vitalsigns when

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    20/28

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    21/28

    Name(BrandName)

    TimingandRoute

    General Classand Family

    Action Considerations

    Magnesium

    Sulfate

    (Epsomsalt,sulfamag)

    2g, PRNmed,IVTT

    Electrolyteimmediate control of life-threatening convulsionsin the treatment of severetoxemias (pre-eclampsia and eclampsia)of pregnancy .

    believed toreduceacetylcholinereleased bynerve impulses,resulting inanticonvulsanteffects andcentral nervoussystemdepression andblockingperipheralneuromusculartransmission.Becausemagnesiumantagonizescalcium andblocks calciumchannels inbronchial andvascular smoothmuscle, it alsohasantihypertensiveactions.

    Flushing,nausea,vomiting,palpitations,headache,generalmuscleweakness,lethargy,constipation.

    serummagnesiumlevels, bloodpressure andrespiratory rateshould bemonitored;patellar reflexescan beassessed todetect onset ofmagnesiumintoxication.

    antidote forrespiratorydepression iscalcium chlorideor calciumgluconate.

    http://www.rxlist.com/script/main/art.asp?articlekey=15915http://www.rxlist.com/script/main/art.asp?articlekey=15915http://www.rxlist.com/script/main/art.asp?articlekey=16443http://www.rxlist.com/script/main/art.asp?articlekey=11893http://www.rxlist.com/script/main/art.asp?articlekey=11893http://www.rxlist.com/script/main/art.asp?articlekey=16443http://www.rxlist.com/script/main/art.asp?articlekey=15915http://www.rxlist.com/script/main/art.asp?articlekey=15915
  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    22/28

    GenericName(BrandName)

    Dosage,TimingandRoute

    ClassificationGeneral Classand Family

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    Ranitidinehydrochloride(Zantac)

    50mg,q8, IVTT

    H2- receptorantagonistantiulcerative

    For occasionalheartburn, acidindigestion,and sourstomach

    Chemical:Competitivelyinhibits actionof H2 receptorsites ofparietal cells,decreasinggastric acidsecretion

    Therapeutic:Relieves GIdiscomfort

    CNS: vertigo,malaiseEENT: blurredvisionHematologic:reversibleleukopenia,pancytopenia,thrombocytopeniaHepatic: jaundiceOther:anaphylaxis,angioedema

    assess patientscondition beforestarting therapy andregularly thereafter tomonitor drugseffectiveness

    be alert for adversereactions and druginteractions

    Dont use aluminium-based needles orequipment whenmixing or giving drugparenterally becausedrug is incompatiblewith aluminum.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    23/28

    Generic Name(Brand Name)

    Dosage,TimingandRoute

    ClassificationGeneral Class andFamily

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    Spironolactone(Aldactone)

    25mg,BID,PO

    Aldosterone

    Antagonist

    Potassium-

    sparing

    diuretic

    Foradjunctivetherapy inedemaandhypertension

    Chemical:Completelyblocks theeffects ofaldosterone in therenaltubule,causingloss ofsodiumand waterandretention ofpotassium.

    Therapeutic:Lowers

    bloodpressure

    CNS:Dizziness,headache,drowsiness,fatigueDermatologic: Rash,UrticariaGI:Cramping,Diarrhea, drymouth, thirst,vomitingGU:impotence,amenorrhea,irregularmensesHematologic

    :Hyperkalemia,HyponatremiaOther:hirsutism

    take the drugearlybecause ofincreasedurination.

    weigh patienton regularbasis at thesame timeand in thesameclothing andrecord theweight.

    avoid foodsthat are richin potassium

    (e.g banana,potatoes,watermelon,tomatoes,nuts, avocado,grapefruitandoranges).

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    24/28

    GenericName(BrandName)

    Dosage,Timing andRoute

    ClassificationGeneral Classand Family

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    Omeprazole(Losec)

    20mg,OD, PO

    Antisecretory

    Drug

    Proton Pump

    Inhibitor

    Short termtreatmentof activeduodenalulcer.

    Chemical:Gastricacid-pumpinhibitor:Suppressesgastric acidsecretion byspecificinhibition ofthehydrogen-potassiumATPaseenzymesystem atthe

    secretorysurface ofthe gastricparietalcells; blocksthe finalstep of acidproduction.

    CNS: Headache,dizziness,vertigo, anxiety,insomniaDermatologic:Rash,inflammation,urticaria, pruritus,alopecia, dryskinGI: Diarrhea,abdominal pain,nausea,vomiting,constipation, drymouth, tongue

    atrophyRespiratory:cough, epistaxisOther: back pain,fever

    take drugbefore meals.

    swallow thecapsulewhole; do notchew, open,or crush themand followwith a glassof water.

    have regularmedicalfollow-upvisits.

    report severeheadache,worsening ofsymptoms,fever, chills.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    25/28

    GenericName(Brand Name)

    Dosage,TimingandRoute

    ClassificationGeneral Classand Family

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    Cefuroxime(Zinacef)

    750mg,q8, IVTT

    Antibiotic

    Cephalospo

    rin (second

    generation)

    To Lowerrespiratoryinfections.

    Chemical:Bactericidal:Inhibits synthesisof bacterial cellwall, causing celldeath.

    CNS:Headache,dizziness,lethargyGI: Nausea,vomiting,diarrhea,anorexia,abdominal pain,flatulenceHematologic:decreasedplateletsHypersensitivity:rash, feverLocal: PainOther:superinfections

    take full courseof therapy evenif feeling better.

    discontinue ifhypersensitivityreaction occurs.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    26/28

    GenericName(Brand Name)

    Dosage,TimingandRoute

    ClassificationGeneral Classand Family

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    Tramadolhydrochloride(Ultram)

    50mg,q8, IVTT

    Analgesic

    Opioid

    analgesic

    Relief ofmoderate tomoderatelysevere pain

    Chemical:Binds to mu-opioidreceptors andinhibits thereuptake ofnorepinephrineand serotonin;causes manyeffects similar tothe opioids--dizziness,somnolence,nausea,constipation-- butdoes not have therespiratorydepressanteffeffects.

    CNS: Sedation,Dizziness,headache,confusion,dreaming,sweating,anxiety,seizuresCV:Hypotension,tachycardia,bradycardiaDermatologic:sweating,pruritus, rash,pallor, urticariaGI: Nausea,vomiting, dry

    mouth,constipation,flatulenceOther:anaphylactoidreactions

    controlenvironment ifsweating orCNS effectsoccur.

    limit in use inpatients withpast or presenthistory ofaddiction to ordependence onopioids.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    27/28

    GenericName(Brand Name)

    Dosage,TimingandRoute

    ClassificationGeneral Classand Family

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    TranexamicAcid(Cyklokapron)

    50mg,q8, PO

    Antifibrinolytic For excessivebleeding

    Chemical:Exerts itsantifibrinolyticeffect through thereversibleblockade oflysine-bindingsites onplasminogenmolecules. Itinhibitsendometrialplasminogenactivator and thuspreventsfibrinolysis andthe breakdown ofblood clots.

    CNS: Headache,dizziness,lethargyGI: Nausea,vomiting,diarrhea,anorexia,abdominal pain,flatulenceHematologic:Arterialthrombosis,thromboembolismHypersensitivity:rash, feverLocal: PainOther:superinfections

    The dose ofCYKLOKAPRON Injectionshould bereduced inpatients withrenalinsufficiencybecause of therisk ofaccumulation.

    Patients with aprevious historyofthromboembolicdisease may beat increased riskfor venous or

    arterialthrombosis.

  • 8/3/2019 Final Drug Study (Eclampsia Patient)

    28/28

    GenericName(Brand Name)

    Dosage,TimingandRoute

    ClassificationGeneral Classand Family

    Indications Mechanism ofAction

    Side Effects NursingConsiderations

    HydralazineHydrochloride(Apresoline)

    5mg, q6,IVTT

    Antihypertensi

    ve

    Vasodilator

    (peripheral)

    For severeessentialhypertension.

    Chemical:Acts directly onvascular smoothmuscle to causevasodilation,primarilyarteriolar,decreasingperipheralresistance;maintains orincreases renaland cerebralblood flow.

    CNS: Headache,peripheral neuritis,dizziness,tremors,anxiety,disorientationCV: Hypotension,tachycardia,palpitations, anginapectorisGI: Nausea,vomiting, dry mouth,anorexia, diarrhea,constipationGU: impotenceHematologic: BlooddyscrasiasHypersensitivity:Rash, urticaria, fever,chills, hepatitis

    Other: nasalcongestion, flushingedema,splenomegaly,dyspnea

    use parenteraldrugimmediatelyafter openingampule. Use asquickly aspossibleafterdrawing to aneedle into asyringe.

    Hydralazinechanges colorafter contactwith metal, anaddiscoloredsolutions shouldbe discarded.